1431950-54-7

Basic information

• Product Name: 4-(bromomethyl)-N-{4-[2-(diethylamino)ethoxy]phenyl}benzenesulfonamide
• Synonyms: 4-(bromomethyl)-N-{4-[2-(diethylamino)ethoxy]phenyl}benzenesulfonamide
• CAS NO: 1431950-54-7
• Molecular Weight: 441.389
• Mol File: 1431950-54-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(bromomethyl)-N-{4-[2-(diethylamino)ethoxy]phenyl}benzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(bromomethyl)-N-{4-[2-(diethylamino)ethoxy]phenyl}benzenesulfonamide(1431950-54-7)
• EPA Substance Registry System: 4-(bromomethyl)-N-{4-[2-(diethylamino)ethoxy]phenyl}benzenesulfonamide(1431950-54-7)

Safety Data

• Hazardous Substances Data: 1431950-54-7(Hazardous Substances Data)

Upstream product

• 38519-63-0 4-[2-(diethylamino)ethoxy]aniline 
• 66176-39-4 4-(bromomethyl)benzene-1-sulfonyl chloride 
• 1431950-51-4 tert-butyl 4-[2-(diethylamino)ethoxy]phenylcarbamate 
• 100-35-6 2-(diethylamino)ethyl chloride 
• 54840-15-2 4-N-tert-butoxycarbonylaminophenol 

Downstream Products

• 1057453-53-8 N-(4-(2-(diethylamino)ethoxy)phenyl)-4-(pyrrolidin-1-ylmethyl)benzene-sulfonamide 
• 1057453-45-8 N-(4-(2-(diethylamino)ethoxy)phenyl)-4-(piperidin-1-ylmethyl)benzene-sulfonamide 
• 1057453-37-8 N-(4-(2-(diethylamino)ethoxy)phenyl)-4-(morpholinomethyl)benzene-sulfonamide 
• 1057460-83-9 C₂₃H₃₄N₄O₃S 

Relevant articles and documents

Benzenesulfonamides: A Unique Class of Chemokine Receptor Type4 Inhibitors

The interaction of CXCR4 with CXCL12 (SDF-1) plays a critical role in cancer metastasis by facilitating the homing of tumor cells to metastatic sites. Based on our previously published work on CXCR4 antagonists, we have synthesized a series of aryl sulfonamides that inhibit the CXCR4/CXCL12 interaction. Analogue bioactivities were assessed with binding affinity and Matrigel invasion assays. Computer modeling was employed to evaluate a selection of the new analogues docked into the CXCR4 X-ray structure and to rationalize discrepancies between the affinity and Matrigel invitro assays. A lead compound displays nanomolar potency in the binding affinity assay (IC50=8.0nM) and the Matrigel invasion assay (100% blockade of invasion at 10nM). These data demonstrate that benzenesulfonamides are a unique class of CXCR4 inhibitors with high potency.